- Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
- Hansa Biopharma: increase in number of shares and votes
- Hansa Biopharma interim report January-March 2024
- Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance
- Hansa Biopharma publishes 2023 Annual and Sustainability Reports
More ▼
Key statistics
On Friday, Hansa Biopharma AB (HNSA:STO) closed at 41.28, -25.35% below its 52-week high of 55.30, set on Aug 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 43.00 |
---|---|
High | 43.60 |
Low | 40.82 |
Bid | 41.10 |
Offer | 41.26 |
Previous close | 43.62 |
Average volume | 261.97k |
---|---|
Shares outstanding | 63.15m |
Free float | 59.05m |
P/E (TTM) | -- |
Market cap | 2.75bn SEK |
EPS (TTM) | -16.07 SEK |
Data delayed at least 15 minutes, as of May 24 2024 16:19 BST.
More ▼